Risk factors for progression in patients with KDOQI stage 3 Chronic Kidney Disease (PROGRESER study).
Martínez-Castelao A, Górriz Teruel JL, D'Marco L, Garrigós E, Fernández-Fresnedo G, Espinel Garuz E, Cigarrán Guldris S, Coloma JA, Robles Pérez-Monteoliva NR, Esteban de la Rosa JR, Nieto Iglesias LJ, Ortiz Arduán A, Navarro-González JF; PROGRESER study investigators; GEENDIAB (Spanish Group for the Study of Diabetic Nephropathy).
Martínez-Castelao A, et al. Among authors: navarro gonzalez jf.
Nefrologia (Engl Ed). 2024 Sep-Oct;44(5):689-699. doi: 10.1016/j.nefroe.2024.10.002. Epub 2024 Nov 6.
Nefrologia (Engl Ed). 2024.
PMID: 39510892
Free article.